Analysis Metabolite Name Measured Value Units Sample Treatment
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.5265Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.5918Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.6002Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.7468Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.7888Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.8319Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.8668Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.8700Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.9117Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.9335Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.9550Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)0.9873Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.0127Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.0266Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.1190Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.1678Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.2923Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.3174Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.3798Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.3984Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.4070Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.5309Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)1.7288Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)2.3750Peak areaFeces Saline

Return to search page
  logo